Molecular Imaging Publications


High Incidence of Severe aGVHD with Tacrolimus and Mycophenolate Mofetil in a Large Cohort of Related and Unrelated Allogeneic Transplant Patients. Biol Blood Marrow Transplant 2014;20:979-85. PMCID: PMC4110977
Authors: Al-Kadhimi Z(01), Gul Z, Chen W(02), Smith D, Abidi M(01), Deol A(01), Ayash L(03), Lum L(01), Waller EK, Ratanatharathorn V(01), Uberti J(01)

Metabotropic glutamate receptor-1 contributes to progression in triple negative breast cancer. PLoS One2014;9:e81126. PMCID: PMC3880256
Authors: A,R,M Banda M, Speyer CL(01), Semma SN, Osuala KO, Kounalakis N, Torres TK, Barnard NJ, Kim HJ, Sloane BF(02), Miller FR, Goydos JS, Gorski DH(03).

Cell type-dependent pathogenic functions of overexpressed human cathepsin B in murine breast cancer progression. Oncogene 2014;33:4474-84. PMCID: PMC4139469
Authors: M Bengsch F, Buck A, Gunther SC, Seiz JR, Tacke M, Pfeifer D, von Elverfeldt D, Sevenich L, Hillebrand LE, Kern U, Sameni M, Peters C, Sloane BF(02), Reinheckel T

A phase 2 cooperative group adjuvant trial using a biomarker-based decision algorithm in patients with stage I non-small cell lung cancer (SWOG-0720, NCT00792701). Cancer 2014;120:2343-51. PMCID: PMC4140446
Authors: M Bepler G(02,03), Zinner RG, Moon J, Calhoun R, Kernstine K, Williams CC, Mack PC, Oliveira V, Zheng Z, Stella PJ, Redman MW, Gandara DR

Evaluating signal-correlated noise as a control task with language-related gamma activity on electrocorticography. Clin Neurophysiol 2014;125:1312-23. PMCID: PMC4035421
Authors: A,R Brown EC, Muzik O(02), Rothermel R, Juhasz C(02), Shah AK, Fuerst D, Mittal S(03), Sood S, Asano E

A phase I, pharmacokinetic and pharmacodynamic study of panobinostat, an HDAC inhibitor, combined with erlotinib in patients with advanced aerodigestive tract tumors. Clin Cancer Res 2014;20:1644-55. PMCID: PMC4051132
Authors: M Gray J, Haura EB, Chiappori A, Tanvetyanon T, Williams CC, Pinder-Schenk M, Kish JA, Kreahling JM, Lush RM, Neuger AM, Tetteh LF, Akar A, Zhao X, Schell MJ, Bepler G(02,03), Altiok S

Axitinib Improves Radiotherapy in Murine Xenograft Lung Tumors. Transl Oncol 2014;0:epub. PMCID: PMC4145357
Authors: A,R Hillman GG(01), Lonardo F(04), Hoogstra DJ, Rakowski J, Yunker CK, Joiner MC(02), Dyson G(04), Gadgeel S(03), Singh-Gupta V

Comparison of FOLFIRI With or Without Cetuximab in Patients With Resected Stage III Colon Cancer; NCCTG (Alliance) Intergroup Trial N0147. Clin Colorectal Cancer 2014;13:100-9. PMCID: PMC4019685
Authors: M Huang J, Nair SG, Mahoney MR, Nelson GD, Shields AF(02), Chan E, Goldberg RM, Gill S, Kahlenberg MS, Quesenberry JT, Thibodeau SN, Smyrk TC, Grothey A, Sinicrope FA, Webb TA, Farr GH, Pockaj BA, Berenberg JL, Mooney M, Sargent DJ, Alberts SR

Patterns of Structural Reorganization of the Corticospinal Tract in Children With Sturge-Weber Syndrome. Pediatr Neurol 2014;50:337-42. PMCID: PMC4048917
Authors: Kamson DO, Juhász C(02), Shin J, Behen ME, Guy WC, Chugani HT, Jeong JW

Increased tryptophan uptake on PET has strong independent prognostic value in patients with a previously treated high-grade glioma. Neuro Oncol 2014;16:1373-83. PMCID: PMC4165412
Authors: A,R Kamson DO, Mittal S(03), Robinette NL, Muzik O(02), Kupsky WJ, Barger GR(03), Juhász C(02).

The value of T2* in differentiating metastatic from benign axillary lymph nodes in patients with breast cancer--a preliminary in vivo study. PLoS One 2014;9:e84038. PMCID: PMC3894179
Authors: M Li C, Meng S, Yang X, Wang J, Hu J(02).

Cytokines secreted by macrophages isolated from tumor microenvironment of inflammatory breast cancer patients possess chemotactic properties. Int J Biochem Cell Biol 2014;46:138-47. PMCID: PMC3928544
Authors: M Mohamed MM, El-Ghonaimy EA, Nouh MA, Schneider RJ, Sloane BF(02), El-Shinawi M.

Capecitabine and Oxaliplatin in the Preoperative Multimodality Treatment of Rectal Cancer: Surgical End Points From National Surgical Adjuvant Breast and Bowel Project Trial R-04. J Clin Oncol 2014;32:1927-34. PMCID: PMC4050205
Authors: M O'Connell MJ, Colangelo LH, Beart RW, Petrelli NJ, Allegra CJ, Sharif S, Pitot HC, Shields AF(02), Landry JC, Ryan DP, Parda DS, Mohiuddin M, Arora A, Evans LS, Bahary N, Soori GS, Eakle J, Robertson JM, Moore DF, Mullane MR, Marchello BT, Ward PJ, Wozniak TF, Roh MS, Yothers G, Wolmark N.

Pleiotropic Associations of Risk Variants Identified for Other Cancers With Lung Cancer Risk: The PAGE and TRICL Consortia. J Natl Cancer Inst 2014;106:4. PMCID: PMC3982896
Authors: R,M Park SL, Fesinmeyer MD, Timofeeva M, Caberto CP, Kocarnik JM, Han Y, Love SA, Young A, Dumitrescu L, Lin Y, Goodloe R, Wilkens LR, Hindorff L, Fowke JH, Carty C, Buyske S, Schumacher FR, Butler A, Dilks H, Deelman E, Cote ML(04), Chen W(02), Pande M, Christiani DC, Field JK, Bickebller H, Risch A, Heinrich J, Brennan P, Wang Y, Eisen T, Houlston RS, Thun M, Albanes D, Caporaso N, Peters U, North KE, Heiss G, Crawford DC, Bush WS, Haiman CA, Landi MT, Hung RJ, Kooperberg C, Amos CI, Le Marchand L, Cheng I.

Glucocorticoid receptor status is a principal determinant of variability in the sensitivity of non-small-cell lung cancer cells to pemetrexed. J Thorac Oncol 2014;9:519-26. PMCID: PMC4075060
Authors: A,R Patki M, Gadgeel S(03), Huang Y, McFall T, Shields AF(02), Matherly LH(03), Bepler G(02,03), Ratnam M(03).

Design and Synthesis of an Inositol Phosphate Analog Based on Computational Docking Studies. Tetrahedron 2014;70:984-990. PMCID: PMC4125022
Authors: Peng Z, Maxwell D, Sun D, Ying Y, Schuber PT Jr, Bhanu Prasad BA, Gelovani J(02), Yung WK, Bornmann WG.

Imatinib analogs as potential agents for PET imaging of Bcr-Abl and c-KIT expression at a kinase level. Bioorg Med Chem 2014;22:623-632. PMCID: PMC4124913A
Authors: Peng Z, Maxwell DS, Sun D, Bhanu PB, Pal A, Wang S, Balatoni J, Ghosh P, Lim ST, Volgin A, Shavrin A, Alauddin MM, Gelovani JG(02), Bornmann WG.

Contrast agents for MRI: 30+ years and where are we going? J Biol Inorg Chem 2014;19:127-131. PMCID: PMC4075138
Authors: Pierre VC, Allen MJ(02), Caravan P.

Choline phosphate cytidylyltransferase-alpha is a novel antigen detected by the anti-ERCC1 antibody 8F1 with biomarker value in patients with lung and head and neck squamous cell carcinomas. Cancer 2014;120:1898-907. PMCID: PMC4047200
Authors: R,M Vaezi AE, Bepler G(02,03), Bhagwat NR, Malysa A, Rubatt JM, Chen W(02), Hood BL, Conrads TP, Wang L, Kemp CE, Niedernhofer LJ.

Cryotherapy with concurrent CpG oligonucleotide treatment controls local tumor recurrence and modulates Her2/neu immunity. Cancer Res 2014;74:5409-20. PMCID: PMC4185007
Authors: A,R,M Veenstra J, Gibson HM, Littrup PJ(02), Reyes JD, Cher ML(01), Takashima A, Wei WZ(01).

Ubiquitination and degradation of ribonucleotide reductase M1 by the polycomb group proteins RNF2 and Bmi1 and cellular response to gemcitabine. PLoS One 2014;9:e91186. PMCID: PMC3948819
Authors: R Zhang Y(03), Li X, Chen Z, Bepler G(02,03).

The Latest From Karmanos Cancer Institute


IN THE NEWS: You're Not Crazy. You Just Have Cancer. The Importance of Behavioral Health Therapy During Cancer Treatment

Coping with Cancer Felicity Harper, Ph.D. , clinical psychologist and member of the Supportive Oncology Multidisciplinary Team at Karmanos, author...

Read More

Genetic counseling now offered at Karmanos’ northern Ohio cancer center

The Barbara Ann Karmanos Cancer Institute now offers genetic counseling services at the Karmanos Cancer Institute at The Toledo Clinic Cancer Cent...

Read More

Are you up to date on your cervical cancer screenings?

  When it comes to cervical cancer , there’s good news: the number of people dying from the disease has decreased. Cervical cancer was once o...

Read More

Cancer death rate decreases by a third | WJR’s The Guy Gordon Show

Listen Now

WebMD Health Discovered – The Fight for Equity in Multiple Myeloma Care

Listen Now

ASCO Education – Impact of Implicit Racial Bias on Oncology Patient Care and Outcomes

Listen Now